These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8619911)

  • 1. Stereological estimation of nuclear mean volume in invasive meningiomas.
    Madsen C; Schrøder HD
    APMIS; 1996 Feb; 104(2):103-7. PubMed ID: 8619911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereological estimation of nuclear volume in benign and atypical meningiomas.
    Madsen C; Schrøder HD
    APMIS; 1993 Jan; 101(1):23-6. PubMed ID: 8457322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereological analysis of nuclear volume in recurrent meningiomas.
    Madsen C; Schrøder HD
    J Neuropathol Exp Neurol; 1994 May; 53(3):272-5. PubMed ID: 8176410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 immunoreactivity in meningiomas--determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67.
    Madsen C; Schrøder HD
    Clin Neuropathol; 1997; 16(3):137-42. PubMed ID: 9197938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.
    Wibom C; Mörén L; Aarhus M; Knappskog PM; Lund-Johansen M; Antti H; Bergenheim AT
    J Neurooncol; 2009 Sep; 94(3):321-31. PubMed ID: 19350207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic meningiomas: an unusual clinical and pathological diagnosis with highly variable outcome.
    Forest F; Berremila SA; Gyenes C; Ginguéné C; Kassir R; Sulaiman A; Pasquier B; Porcheron J; Péoc'h M
    J Neurooncol; 2014 Nov; 120(2):411-21. PubMed ID: 25081976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis in meningioma.
    Enam SA; Abdulrauf S; Mehta B; Malik GM; Mahmood A
    Acta Neurochir (Wien); 1996; 138(10):1172-7; discussion 1177-8. PubMed ID: 8955436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsins B and L are markers for clinically invasive types of meningiomas.
    Strojnik T; Zidanik B; Kos J; Lah TT
    Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Benign" metastasizing meningiomas.
    Som PM; Sacher M; Strenger SW; Biller HF; Malis LI
    AJNR Am J Neuroradiol; 1987; 8(1):127-30. PubMed ID: 3101455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors.
    Salmon I; Kiss R; Levivier M; Remmelink M; Pasteels JL; Brotchi J; Flament-Durand J
    Am J Surg Pathol; 1993 Mar; 17(3):239-47. PubMed ID: 8434704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical and malignant meningiomas: a clinicopathological review.
    Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
    Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On diagnostics of malignant meningioma and invasive meningioma].
    Zhang S; Meng H; Gui Y; Chen L; Zhao T; Zhang X; Li G; Yang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):192-5. PubMed ID: 9389041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
    Perry A; Scheithauer BW; Stafford SL; Lohse CM; Wollan PC
    Cancer; 1999 May; 85(9):2046-56. PubMed ID: 10223247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.
    Spille DC; Heß K; Sauerland C; Sanai N; Stummer W; Paulus W; Brokinkel B
    World Neurosurg; 2016 Sep; 93():346-54. PubMed ID: 27344043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach.
    Christensen D; Laursen H; Klinken L
    Acta Neuropathol; 1983; 61(2):130-4. PubMed ID: 6637397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningiomas presenting in the temporal bone: the pathways of spread from an intracranial site of origin.
    Chang CY; Cheung SW; Jackler RK
    Otolaryngol Head Neck Surg; 1998 Dec; 119(6):658-64. PubMed ID: 9852544
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
    Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
    Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies.
    Hashimoto N; Rabo CS; Okita Y; Kinoshita M; Kagawa N; Fujimoto Y; Morii E; Kishima H; Maruno M; Kato A; Yoshimine T
    J Neurosurg; 2012 Mar; 116(3):574-80. PubMed ID: 22175721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.